First Regular Session of the 124th General Assembly (2025)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2024 Regular Session of the General Assembly.
HOUSE ENROLLED ACT No. 1065
AN ACT to amend the Indiana Code concerning health.
Be it enacted by the General Assembly of the State of Indiana:
SECTION 1. IC 16-18-2-45.1 IS ADDED TO THE INDIANA
CODE AS A NEW SECTION TO READ AS FOLLOWS
[EFFECTIVE JULY 1, 2025]: Sec. 45.1. "Cancer clinical trial", for
purposes of IC 16-48-18, has the meaning set forth in
IC 16-46-18-1.
SECTION 2. IC 16-18-2-268.1 IS ADDED TO THE INDIANA
CODE AS A NEW SECTION TO READ AS FOLLOWS
[EFFECTIVE JULY 1, 2025]: Sec. 268.1. "Participant", for
purposes of IC 16-48-18, has the meaning set forth in
IC 16-46-18-2.
SECTION 3. IC 16-18-2-294.5, AS AMENDED BY P.L.208-2015,
SECTION 4, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2025]: Sec. 294.5. (a) "Program", for purposes of IC 16-40-4,
has the meaning set forth in IC 16-40-4-3.
(b) "Program", for purposes of IC 16-41-7.5, has the meaning set
forth in IC 16-41-7.5-2.
(c) "Program", for purposes of IC 16-46-18, has the meaning set
forth in IC 16-46-18-3.
(c) (d) "Program", for purposes of IC 16-47-1, has the meaning set
forth in IC 16-47-1-3.
SECTION 4. IC 16-46-18 IS ADDED TO THE INDIANA CODE
AS A NEW CHAPTER TO READ AS FOLLOWS [EFFECTIVE
HEA 1065 2
JULY 1, 2025]:
Chapter 18. Cancer Clinical Trial Participation Program
Sec. 1. As used in this chapter, "cancer clinical trial" refers to
a research study in which an individual receives a new cancer
treatment, including medication, chemotherapy, or adult stem cell
therapy.
Sec. 2. As used in this chapter, "participant" refers to an
individual who participates in a program.
Sec. 3. As used in this chapter, "program" means a cancer
clinical trial participation program described in section 4 of this
chapter.
Sec. 4. An organization or entity may establish and administer
a program for the purpose of providing payment to a participant
for reasonable costs incurred by a participant while participating
in a cancer clinical trial.
Sec. 5. (a) An organization or entity that establishes and
administers a program shall do the following:
(1) Subject to section 6 of this chapter, establish guidelines for
financial eligibility for the program, which must be based on
financial need.
(2) Collaborate with health care providers to notify a
prospective participant about the program.
(3) Provide written notice to a prospective participant on the:
(A) requirements described in this section;
(B) nature and availability of financial support provided
under the program; and
(C) program's financial eligibility guidelines.
(4) Receive and review applications for participation in the
program.
(5) Establish a process for awarding payments.
(6) Subject to approval by the organization or entity, provide
payment to a participant for reasonable costs incurred by the
participant while participating in a cancer clinical trial,
including costs for the following:
(A) Travel.
(B) Lodging.
(C) Parking and tolls.
(D) Other costs, as determined by the organization or
entity.
(7) Comply with all applicable state and federal laws.
(b) An organization or entity that establishes and administers a
program may, in addition to payments provided to a participant,
HEA 1065 3
provide to one (1) individual, including a relative or friend,
designated by a participant payment for reasonable costs described
in subsection (a)(6) incurred while the individual attends a cancer
clinical trial to support the participant.
Sec. 6. An individual is eligible to participate in a program if the
individual:
(1) is an Indiana resident;
(2) has an income that does not exceed seven hundred percent
(700%) of the federal poverty level;
(3) resides in an underserved area, as determined by the
organization or entity; and
(4) is eligible to participate in a cancer clinical trial.
Sec. 7. An organization or entity that operates a program may
accept gifts, grants, and donations from a public or private source
to establish and administer the program.
HEA 1065 Speaker of the House of Representatives
President of the Senate
President Pro Tempore
Governor of the State of Indiana
Date: Time:
HEA 1065